Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,718 | 8,828 | 12,178 | 9,650 | 6,694 |
| Cost of Goods | 2,804 | 3,826 | 4,794 | 4,081 | 2,962 |
| Gross Profit | 4,914 | 5,002 | 7,384 | 5,569 | 3,732 |
| Operating Expenses | 9,804 | 11,273 | 10,184 | 11,308 | 12,848 |
| Operating Income | -4,086 | -5,445 | -2,006 | -5,658 | -8,154 |
| Interest Expense | 370 | 405 | 331 | 337 | 460 |
| Other Income | 157 | -176 | -487 | -995 | -1,526 |
| Pre-tax Income | -4,299 | -6,026 | -2,824 | -6,990 | -10,140 |
| Income Tax | -88 | 37 | 46 | 34 | N/A |
| Net Income Continuous | -4,211 | -6,063 | -2,870 | -7,024 | -10,140 |
| Net Income | $-4,211 | $-6,063 | $-2,870 | $-7,024 | $-10,140 |
| EPS Basic Total Ops | -0.03 | -0.04 | -0.02 | -0.05 | -0.08 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.02 | -0.05 | -0.08 |
| EPS Diluted Total Ops | -0.03 | -0.04 | -0.02 | -0.05 | -0.08 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.02 | -0.05 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.04 | N/A | N/A | N/A |
| EBITDA(a) | $-2,977 | $-4,364 | $-928 | $-4,561 | $-7,029 |